Skip to content

Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers

Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00001164
Enrollment
Unknown
Registered
2002-12-10
Start date
1978-07-31
Completion date
2000-06-30
Last updated
2008-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Muscular Dystrophy, Retinal Degeneration, Skin Diseases, Virus Diseases

Keywords

Genetic Evaluation, Immunologic Evaluations, Inflammatory Skin Disease, Muscular Dystrophies, Neoplastic Skin Diseases, Neuronal Degenerations, Retinal Degenerations, Viral Diseases

Brief summary

It is proposed that patients with skin disease due to presumed immunologic, genetic or viral-induced abnormalities, patients with neurological degenerations, and normal controls be evaluated with various in vitro studies of immunologic, genetic, and virologic function. This is to include studies of peripheral blood (cells and serum) as well as studies of skin obtained with a biopsy instrument. In addition, studies of gastrointestinal function will be performed where appropriate.

Detailed description

It is proposed that patients with skin disease due to presumed immunologic, genetic or viral-induced abnormalities, patients with neurological degenerations, and normal controls be evaluated with various in vitro studies of immunologic, genetic, and virologic function. This is to include studies of peripheral blood (cells and serum) as well as studies of skin obtained with a biopsy instrument. In addition, studies of gastrointestinal function will be performed where appropriate.

Interventions

None listed

Sponsors

National Cancer Institute (NCI)
Lead SponsorNIH

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

Patients with skin diseases of presumed genetic, immunologic, or virologic origin are eligible. Patients with neurological degenerations are eligible, including patients with inflammatory, neoplastic and viral skin diseases and also heterozygous carriers of such inherited diseases. Volunteers without skin diseases are eligible, except children.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026